203 related articles for article (PubMed ID: 33727578)
61. hsa_circ_102559 Acts as the Sponge of miR-130a-5p to Promote Hepatocellular Carcinoma Progression Through Regulation of ANXA2.
Li J; Yu Z; Zhu Q; Tao C; Xu Q
Cell Transplant; 2020; 29():963689720968748. PubMed ID: 33121269
[TBL] [Abstract][Full Text] [Related]
62. hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis.
Zhou XY; Yang H; Bai YQ; Li XL; Han SY; Zhou BX
Cell Mol Biol Lett; 2020 Nov; 25(1):47. PubMed ID: 33292166
[TBL] [Abstract][Full Text] [Related]
63. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
[TBL] [Abstract][Full Text] [Related]
64. Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells.
Zhao M; Dong G; Meng Q; Lin S; Li X
J Cell Biochem; 2020 Nov; 121(11):4440-4449. PubMed ID: 32037619
[TBL] [Abstract][Full Text] [Related]
65. Serum hsa_circ_0000615 is a prognostic biomarker of sorafenib resistance in hepatocellular carcinoma.
Zhang L; Xu T; Li Y; Pang Q; Ding X
J Clin Lab Anal; 2022 Nov; 36(11):e24741. PubMed ID: 36268976
[TBL] [Abstract][Full Text] [Related]
66. Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma.
Chen D; Zhang C; Lin J; Song X; Wang H
Cancer Manag Res; 2018; 10():1275-1283. PubMed ID: 29849467
[TBL] [Abstract][Full Text] [Related]
67. Silencing circular RNA hsa_circ_0004491 promotes metastasis of oral squamous cell carcinoma.
Li X; Zhang H; Wang Y; Sun S; Shen Y; Yang H
Life Sci; 2019 Dec; 239():116883. PubMed ID: 31669576
[TBL] [Abstract][Full Text] [Related]
68. High throughput circRNA sequencing analysis reveals novel insights into the mechanism of nitidine chloride against hepatocellular carcinoma.
Xiong DD; Feng ZB; Lai ZF; Qin Y; Liu LM; Fu HX; He RQ; Wu HY; Dang YW; Chen G; Luo DZ
Cell Death Dis; 2019 Sep; 10(9):658. PubMed ID: 31506425
[TBL] [Abstract][Full Text] [Related]
69. Screening differential circular RNA expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma.
Fu L; Yao T; Chen Q; Mo X; Hu Y; Guo J
Oncotarget; 2017 Aug; 8(35):58405-58416. PubMed ID: 28938566
[TBL] [Abstract][Full Text] [Related]
70. Circular RNA hsa_Circ_101141 as a Competing Endogenous RNA Facilitates Tumorigenesis of Hepatocellular Carcinoma by Regulating miR-1297/ROCK1 Pathway.
Zhang T; Zhang L; Han D; Tursun K; Lu X
Cell Transplant; 2020; 29():963689720948016. PubMed ID: 32787581
[TBL] [Abstract][Full Text] [Related]
71. Nomograms incorporating hsa_circ_0029325 highly expressed in exosomes of hepatocellular carcinoma predict the postoperative outcomes.
Yin KL; Sun T; Duan YX; Ye WT; Ming Li ; Liao R
Discov Oncol; 2024 Jun; 15(1):212. PubMed ID: 38836972
[TBL] [Abstract][Full Text] [Related]
72. Overexpression of hsa_circ_0001715 is a Potential Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma.
Lu GJ; Cui J; Qian Q; Hou ZB; Xie HY; Hu W; Hao KK; Xia N; Zhang Y
Onco Targets Ther; 2020; 13():10775-10783. PubMed ID: 33122916
[TBL] [Abstract][Full Text] [Related]
73. The Circular RNA hsa_circ_0001445 Regulates the Proliferation and Migration of Hepatocellular Carcinoma and May Serve as a Diagnostic Biomarker.
Zhang X; Zhou H; Jing W; Luo P; Qiu S; Liu X; Zhu M; Liang C; Yu M; Tu J
Dis Markers; 2018; 2018():3073467. PubMed ID: 29785229
[TBL] [Abstract][Full Text] [Related]
74. Role and mechanism of circ-PRKCI in hepatocellular carcinoma.
Qi SX; Sun H; Liu H; Yu J; Jiang ZY; Yan P
World J Gastroenterol; 2019 Apr; 25(16):1964-1974. PubMed ID: 31086464
[TBL] [Abstract][Full Text] [Related]
75. circ_0067934: A Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma.
Zhou C; Li R; Mi W
Ann Clin Lab Sci; 2020 Nov; 50(6):734-738. PubMed ID: 33334787
[TBL] [Abstract][Full Text] [Related]
76. Identification of RNA binding protein interacting with circular RNA and hub candidate network for hepatocellular carcinoma.
Cheng B; Tian J; Chen Y
Aging (Albany NY); 2021 Jun; 13(12):16124-16143. PubMed ID: 34133325
[TBL] [Abstract][Full Text] [Related]
77. Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma.
Zhao SY; Wang J; Ouyang SB; Huang ZK; Liao L
Cell Physiol Biochem; 2018; 47(6):2511-2521. PubMed ID: 29991057
[TBL] [Abstract][Full Text] [Related]
78. Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer.
Liu L; Wu SQ; Zhu X; Xu R; Ai K; Zhang L; Zhao XK
Neoplasma; 2019 Sep; 66(5):736-745. PubMed ID: 31169020
[TBL] [Abstract][Full Text] [Related]
79. Development of a two-circular RNA panel as potential prognostic biomarker for gastric cancer.
Liu J; Zhu X; Yan M; Li H
J Transl Med; 2021 Oct; 19(1):412. PubMed ID: 34600555
[TBL] [Abstract][Full Text] [Related]
80. Plasma hsa_circ_0027089 is a diagnostic biomarker for hepatitis B virus-related hepatocellular carcinoma.
Zhu K; Zhan H; Peng Y; Yang L; Gao Q; Jia H; Dai Z; Tang Z; Fan J; Zhou J
Carcinogenesis; 2020 May; 41(3):296-302. PubMed ID: 31535687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
